CA1322331C - Galenical formulations - Google Patents

Galenical formulations

Info

Publication number
CA1322331C
CA1322331C CA000544704A CA544704A CA1322331C CA 1322331 C CA1322331 C CA 1322331C CA 000544704 A CA000544704 A CA 000544704A CA 544704 A CA544704 A CA 544704A CA 1322331 C CA1322331 C CA 1322331C
Authority
CA
Canada
Prior art keywords
composition according
nasal
sms
octreotide
powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000544704A
Other languages
English (en)
French (fr)
Inventor
Moise Azria
Thomas Cavanak
Wolfgang Doepfner
Andreas Rummelt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868620035A external-priority patent/GB8620035D0/en
Priority claimed from GB868626821A external-priority patent/GB8626821D0/en
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of CA1322331C publication Critical patent/CA1322331C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/31Somatostatins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CA000544704A 1986-08-18 1987-08-17 Galenical formulations Expired - Fee Related CA1322331C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8620035 1986-08-18
GB868620035A GB8620035D0 (en) 1986-08-18 1986-08-18 Organic compounds
GB868626821A GB8626821D0 (en) 1986-11-10 1986-11-10 Organic compounds
GB8626821 1986-11-10

Publications (1)

Publication Number Publication Date
CA1322331C true CA1322331C (en) 1993-09-21

Family

ID=26291187

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000544704A Expired - Fee Related CA1322331C (en) 1986-08-18 1987-08-17 Galenical formulations

Country Status (24)

Country Link
KR (1) KR880002537A (pt)
AT (1) AT396331B (pt)
AU (2) AU612589B2 (pt)
BE (1) BE1001748A4 (pt)
CA (1) CA1322331C (pt)
CH (1) CH672252A5 (pt)
CS (1) CS411491A3 (pt)
DE (1) DE3726517A1 (pt)
DK (1) DK428287A (pt)
ES (1) ES2004807A6 (pt)
FI (1) FI93307C (pt)
FR (1) FR2602680B1 (pt)
GR (1) GR871289B (pt)
HK (1) HK80493A (pt)
HU (1) HU200940B (pt)
IE (1) IE60761B1 (pt)
IL (1) IL83572A (pt)
IT (1) IT1222510B (pt)
LU (1) LU86971A1 (pt)
NL (1) NL8701874A (pt)
NO (1) NO175519C (pt)
NZ (1) NZ221473A (pt)
PT (1) PT85545B (pt)
SE (1) SE8703183L (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1485117A4 (en) 2002-01-22 2006-03-22 Univ New York METHOD FOR THERAPEUTIC TREATMENT OF BENIGN PROSTATE HYPERTROPHY (BPH)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
DE3062075D1 (en) * 1979-11-27 1983-03-24 Sandoz Ag Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use
US4451394A (en) * 1982-10-25 1984-05-29 American Home Products Corporation Dodecapeptides preventing glucose and triglyceride assimilation
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US4505897A (en) * 1983-04-18 1985-03-19 The Administrators Of The Tulane Educational Fund Cyclic pentapeptides displaying somatostatin antagonism and method of treatment of mammals therewith
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
US4612302A (en) * 1983-11-14 1986-09-16 Brigham And Women's Hospital Clinical use of somatostatin analogues
JPS60224616A (ja) * 1984-04-24 1985-11-09 Teijin Ltd 経鼻投与用組成物
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
JPH085913B2 (ja) * 1985-09-12 1996-01-24 ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド 治療用ソマトスタチン同族体

Also Published As

Publication number Publication date
KR880002537A (ko) 1988-05-09
NZ221473A (en) 1990-08-28
IT8721670A0 (it) 1987-08-18
NO175519C (no) 1994-10-26
FR2602680B1 (fr) 1993-04-16
IL83572A (en) 1992-09-06
SE8703183D0 (sv) 1987-08-17
ES2004807A6 (es) 1989-02-01
LU86971A1 (fr) 1988-03-02
AT396331B (de) 1993-08-25
NO175519B (no) 1994-07-18
ATA206087A (de) 1992-12-15
PT85545A (en) 1987-09-01
SE8703183L (sv) 1988-02-19
IE872187L (en) 1988-02-18
NO873452D0 (no) 1987-08-17
DK428287A (da) 1988-02-19
IE60761B1 (en) 1994-08-10
FI93307C (fi) 1995-03-27
IT1222510B (it) 1990-09-05
NO873452L (no) 1988-02-19
FI93307B (fi) 1994-12-15
FI873548A0 (fi) 1987-08-17
AU637530B2 (en) 1993-05-27
AU8568991A (en) 1991-12-05
AU612589B2 (en) 1991-07-18
DK428287D0 (da) 1987-08-17
AU7712087A (en) 1988-02-25
FI873548A (fi) 1988-02-19
BE1001748A4 (fr) 1990-02-27
DE3726517A1 (de) 1988-03-03
PT85545B (pt) 1990-05-31
NL8701874A (nl) 1988-03-16
GR871289B (en) 1987-12-18
CH672252A5 (pt) 1989-11-15
HU200940B (en) 1990-09-28
HUT46235A (en) 1988-10-28
CS411491A3 (en) 1992-06-17
HK80493A (en) 1993-08-13
FR2602680A1 (fr) 1988-02-19
IL83572A0 (en) 1988-01-31

Similar Documents

Publication Publication Date Title
GB2193891A (en) Nasal pharmaceutical compositions containing octreotide
US5011678A (en) Composition and method for administration of pharmaceutically active substances
CA2115444C (en) Preparation for intratracheobronchial administration
US4746508A (en) Drug administration
US5725852A (en) Transmucosal therapeutic composition
US4959358A (en) Drug administration
JP3818852B2 (ja) 肺への薬物送達
KR920005965B1 (ko) 코로 투약하는 벤조디아제핀 최면제
KR101058467B1 (ko) 부신피질 자극 호르몬 유사체 및 관련 방법
US6197328B1 (en) Nasally administrable compositions
US4988512A (en) Nasal pharmaceutical compositions
JP2003525891A (ja) 口腔及び経肺投与用薬学的組成物
EP0327756B1 (en) Pharmaceutical compositions comprising a calcitonin and a glycyrrhizinate as absorption enhancer
JP2003522096A (ja) 混合ミセル状薬剤の移送システム及び調製方法
JPS61194034A (ja) 経鼻投与用粉末状組成物
NO178564B (no) Framgangsmåte for framstilling av et system for administrering av aktive medikamenter gjennom slimhinner
JP2002532536A (ja) 口及び肺に適用されるエアロゾル調製物
RO121834B1 (ro) Dispozitiv pentru administrarea unui agent activ
GB2248550A (en) Nasal pharmaceutical composition
JP2003533469A (ja) 口腔及び経肺投与用ミセル薬学的組成物
HU219461B (hu) Eljárás parenterális gyógyszerkészítmények farmakokinetikai és farmakológiai tulajdonságai szabályozásának javítására
EP1200066B1 (en) Aqueous nasal formulation
CA1322331C (en) Galenical formulations
AU709783B2 (en) Aerosol drug formulations containing vitamin E
CA1329764C (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
MKLA Lapsed